Home_Jiangsu Synthgene Biotechnology Co., Ltd.



Jiangsu Synthgene Biotechnology Co., Ltd.

搜索

Search

Language

中文简体

English





Customer Service

Customized service

Detection service

Discovery Products

Company Profile

Synthgene Biotechnology Co., Ltd. is a company that provides materials and services to support mRNA and oligonucleotide manufacturing. Founded in 2018 by a group of passionate nucleic acid chemists, the goal of the company is to debottleneck the raw material supply and develop innovative solutions to support customers in the industry. The company has a robust quality system and ISO9001 certification to support cGMP manufacturing of mRNA raw materials that include NTPs, modified NTPs and cap analogs. For the GMP raw materials, Drug Master Files have been filed with FDA. In addition, Synthgene offers analytical development service and mRNA-related impurity standards and detection kits, LNP screening service, IVT process development and IVT kits for mRNA research. For solid-phase DNA and RNA synthesis, Synthgene offers high quality phosphonamidites to support cGMP oligo manufacturing. With over 200 people in R&D and AI-assisted discovery platform, Synthgene will continue to bring new products to the market.

Recent show

If you need certificate of analysis（COA）

please click to fill in the relevant information or contact us by email！

Download

News Center

SYNTHGENE丨Boston Double Show

 2023-06-01  0

SYNTHGENE & World Vaccine Congress Washington 2023

 2023-04-01  0

Congratulations| Synthgene Biotechnology Appoints HongYuan Chen, Academician of Chinese Academy of Sciences, as Chief Scientist

After the visit, Chairman Tong Kun and other company executives had a discussion and exchange in the meeting room with Academician Hongyuan Chen. During the meeting, Chairman Tong Kun first expressed his gratitude to Academician Chen for his visit and guidance, and then introduced the company in detail the entrepreneurial team, entrepreneurial development process, main business directions and business situation to Academician Chen. In the course of more than 3 years of company development, Synthgene has always adhered to the entrepreneurial spirit of “Dive Deep Stay True" for technology R&D and product development around the antigens, antibodies, enzymes, nucleotides and other core raw materials, and has successively entered the upstream core raw materials of IVD, mRNA, CGT and other industries. At the same time, a high-quality key common technology platform has been established to provide downstream customers with overall solutions!

 2021-11-16  0

The event is in progress | The 53rd MEDICA opened grandly, looking back on the wonderful first day of Synthgene Medical Technology!

On November 15, 2021, the world's largest medical equipment industry exhibition, the German International Hospital and Medical Equipment Supplies Exhibition (MEDICA), grandly opened in Dusseldorf, Germany. This MEDICA exhibition attracted more than 200,000 exhibitors from more than 100 countries, and experts from various countries gathered to discuss and exchange medical cutting-edge technology. For the first time of MDICIA, Synthgene Medical Technology showed a variety of products, which attracted much attention.

 2021-11-16  0

Looking ahead of the tide, shining brilliantly丨Synthgene Medical shines in Nanchang CACLP

　　From August 21 to August 23, CACLP was held in Nanchang Greenland International Expo Center, and many famous celebrities participated in the event. The annual CACLP is a professional exhibition with great influence and gathering power in the field of in vitro diagnostics. After nearly 20 years of development, it has grown into a flagship exposition in the field of IVD with the joint efforts of the organizer and all the exhibitors and participants. CACLP is an event that focuses on the display of IVD products and truly reflects the progress and development of the industry! It is an event for IVD brands to appear in full vigor and cover the whole industry chain to explore the development opportunities of enterprises and collect cutting-edge information! It is an event to build sales channels and establish contacts to help enterprises to move forward, and to discuss the future of laboratory medicine 　　With the theme of "Intelligence, Convergence, Innovation", this year's CACLP focuses on 5G and artificial intelligence, and uses top technologies such as big data, intelligence, mobile, cloud, and IoT to promote the development and progress of the in vitro diagnostic industry. 　　Nanjing Synthgene Medical Technology shines at this conference with more than 30 kinds of in vitro diagnostic raw materials, such as inflammation and infection, cardiovascular, renal function, gastric function, and tumor markers. 第十七届国际检验医学暨输血仪器试剂博览会圆满落幕，申基医药愿以品牌的力量共同筑建体外诊断美好的明天！

 2021-08-21  11

2020·CACLP The 17th International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo

An annual grand event for in vitro diagnostics with strong professionalism, large scale, wide influence and rich information-the 17th International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (CACLP) is scheduled to be held from August 21 to 23, 2020 Grandly held at Nanchang Greenland International Expo Center, it is a grand event to build sales channels and establish personal connections to help companies advance production, learning, research, application, and transformation to talk about the future of laboratory medicine!

 2020-08-18  0



